Article info

Download PDFPDF

Original research
Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease

Authors

  1. Correspondence to Mr Einar Smith, Department of Clinical Sciences, Lund University, Malmö 21428, Sweden; einar.smith{at}med.lu.se
View Full Text

Citation

Smith E, Ottosson F, Hellstrand S, et al
Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease

Publication history

  • Received May 29, 2019
  • Revised September 19, 2019
  • Accepted October 1, 2019
  • First published October 31, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.